← Back to headlines
Kailera Stock Soars Over 60% in Nasdaq Debut After $625M IPO
Biotech company Kailera made a strong debut on Nasdaq, raising $625 million in one of the largest biotech IPOs ever. Its stock soared over 60% on its first day of trading, driven by its involvement in the weight-loss drug market.
16 Apr, 20:38 — 17 Apr, 18:09
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center1
Center (1)
Reuters
Right
Far R
Geographic diversity— 2 regions9/34
Intl1US1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
ReutersVery High115d ago
Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats up - Reuters
Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats up Reuters
Read full article →YahooMostly Factual116d ago
Kailera nets $625M in one of biotech’s biggest-ever IPOs
Read full article →Coverage Timeline
First report: Yahoo · 16 Apr, 20:38|Full coverage: 2 · 22h|Window: 22h
Left-leaningCenterRight-leaning
